Liebert Debra K. 4
4 · Milestone Pharmaceuticals Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Liebert Debra K.
Director
Transactions
- Award
Series B Common Warrants (right to buy)
2025-07-11+16,793→ 16,793 totalExercise: $1.88Exp: 2030-07-11→ Common Shares (16,793 underlying) - Award
Common Shares
2025-07-11+16,666→ 16,793 total - Award
Series A Common Warrants (right to buy)
2025-07-11+16,793→ 16,793 totalExercise: $1.50Exp: 2026-07-11→ Common Shares (16,793 underlying)
Holdings
- 10,000(indirect: By Trust)
Common Shares
- 4,000(indirect: By Trust)
Common Shares
Footnotes (3)
- [F1]The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock.
- [F2]These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]Fully vested and exercisable.